Am J Perinatol 2022; 39(11): 1151-1158
DOI: 10.1055/a-1788-5894
SMFM Fellowship Series Article

Temporal Trends in Postpartum Opioid Prescribing, Opioid Use, and Pain Control Satisfaction

Nevert Badreldin
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Julia D. DiTosto
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
William Grobman
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Lynn M. Yee
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
› Institutsangaben
Funding This study is supported by the Society for Maternal-Fetal Medicine/AMAG 2017 Health Policy Award. L.M.Y. was supported by the NICHD K12 HD05021 at the time of this study. Research reported in this publication was supported, in part, by the National Institutes of Health's National Center for Advancing Translational Sciences, Grant Number UL1TR001422. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Abstract

Objective The objective was to assess temporal trends in postpartum opioid prescribing, opioid use, and pain control satisfaction.

Study Design This is a prospective observational study of postpartum patients who delivered at a large tertiary care center (May 2017–July 2019). Inpatient patients were screened for eligibility; those meeting eligibility criteria who used inpatient opioids were approached for prospective survey participation which probed inpatient and outpatient postpartum pain control. The amount of opioids used during inpatient hospitalization and the amount of opioids prescribed at discharge were obtained from medical records. The primary outcome was the difference in opioid prescribing at discharge over time, measured by (1) the proportion of participants who received an opioid prescription at discharge and (2) for those who received an opioid prescription, the total morphine milligram equivalents of the prescription. Additional outcomes were inpatient and outpatient opioid use and patient-reported satisfaction with postpartum pain control. Trends over time were evaluated using nonparametric tests of trend.

Results Of 2,503 postpartum patients screened for eligibility, a majority (N = 1,425; 60.8%) did not use an opioid as an inpatient. Over the study period, there was a significant decline in the proportion of patients who used an opioid while inpatient (z-score =  − 11.8; p < 0.01). Among these participants enrolled in the prospective survey study (N = 494), there was a significant decline over time in the amount of inpatient opioid use (z-score =  − 2.4; p = 0.02), the proportion of participants who received an opioid prescription upon discharge (z-score =  − 8.2; p < 0.01), and, when an opioid was prescribed at discharge, the total prescribed morphine milligram equivalents (z-score =  − 4.3; p < 0.01). Both inpatient and outpatient satisfactions with pain control were unchanged over this time (z-score = 1.1, p = 0.27; z-score = 1.1, p = 0.29, respectively).

Conclusion In this population, both the frequency and amount of opioid use in the postpartum period declined from 2017 to 2019. This decrease in opioid prescribing was not associated with changes in patient-reported satisfaction with pain control.

Key Points

  • From 2017 to 2019, there was a decrease in inpatient and outpatient postpartum opioid use.

  • Both the proportion of postpartum patients receiving opioid prescriptions and the amount prescribed decreased.

  • Patient satisfaction with postpartum pain control remained unchanged.

Presentation

These data were presented as a poster at the 2020 Society of Maternal-Fetal Medicine 40th Annual Meeting in Dallas, TX (February 3–8, 2020).




Publikationsverlauf

Eingereicht: 12. Oktober 2021

Angenommen: 18. Februar 2022

Accepted Manuscript online:
04. März 2022

Artikel online veröffentlicht:
17. Mai 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wilson N, Kariisa M, Seth P, Smith IV H, Davis NL. Drug and opioid-involved overdose deaths - United States, 2017-2018. Morb Mortal Wkly Rep 2020; 69 (11) 290-297
  • 2 Guy Jr GP, Zhang K, Bohm MK. et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017; 66 (26) 697-704
  • 3 Hadlandsmyth K, Mosher H, Vander Weg MW, Lund BC. Decline in prescription opioids attributable to decreases in long-term use: a retrospective study in the veterans health administration 2010-2016. J Gen Intern Med 2018; 33 (06) 818-824
  • 4 Jairam V, Yang DX, Pasha S. et al. Temporal trends in opioid prescribing patterns among oncologists in the medicare population. J Natl Cancer Inst 2021; 113 (03) 274-281
  • 5 Keller DS, Kenney BC, Harbaugh CM, Waljee JF, Brummett CM. A national evaluation of opioid prescribing and persistent use after ambulatory anorectal surgery. Surgery 2021; 169 (04) 759-766
  • 6 Polychronopoulou E, Raji MA, Wolf SE, Kuo YF. US national trends in prescription opioid use after burn injury, 2007 to 2017. Surgery 2021; 170 (03) 952-961
  • 7 Zipursky JS, Pang A, Paterson JM. et al. Trends in postpartum opioid prescribing: a time series analysis. Clin Pharmacol Ther 2021; 110 (04) 1004-1010
  • 8 McDermott KW, Elixhauser A, Sun R. Trends in hospital inpatient stays in the United States, 2005–2014. HCUP Statistical Brief #225. June 2017. Agency for healthcare Research and Quality, Rockville, MD. Accessed March 16, 2022 at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb225-Inpatient-US-Stays-Trends.pdf
  • 9 Badreldin N, Grobman WA, Yee LM. Inpatient opioid use after vaginal delivery. Am J Obstet Gynecol 2018; 219 (06) 608.e1-608.e7
  • 10 Rogers RG, Nix M, Chipman Z. et al. Decreasing opioid use postpartum: a quality improvement initiative. Obstet Gynecol 2019; 134 (05) 932-940
  • 11 Mills JR, Huizinga MM, Robinson SB. et al. Draft opioid-prescribing guidelines for uncomplicated normal spontaneous vaginal birth. Obstet Gynecol 2019; 133 (01) 81-90
  • 12 Centers for Disease Control and Prevention. 2018 . The US Opioid Crisis: Addressing Maternal and Infant Health. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion. Accessed March 16, 2022 at: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/substance-abuse/opioid-use-disorder-pregnancy/pdf/MMWR-Opioids-Use-Disorder-Pregnancy-Infographic-h.pdf
  • 13 ACOG Committee Opinion No. ACOG Committee Opinion No. 742: postpartum pain management. Obstet Gynecol 2018; 132 (01) e35-e43
  • 14 Grobman WA, Bailit JL, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol 2014; 123 (04) 804-810
  • 15 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 16 Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep 2016; 65 (01) 1-49
  • 17 Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4 (01) 87-90
  • 18 Badreldin N, Grobman WA, Chang KT, Yee LM. Opioid prescribing patterns among postpartum women. Am J Obstet Gynecol 2018; 219 (01) 103.e1-103.e8
  • 19 Bateman BT, Cole NM, Maeda A. et al. Patterns of opioid prescription and use after cesarean delivery. Obstet Gynecol 2017; 130 (01) 29-35
  • 20 Jain JA, Temming LA, D'Alton ME. et al. SMFM Special Report: putting the “M” back in MFM: reducing racial and ethnic disparities in maternal morbidity and mortality: a call to action. Am J Obstet Gynecol 2018; 218 (02) B9-B17
  • 21 Zhu Y, Huybrechts KF, Desai RJ. et al. Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse. Am J Obstet Gynecol MFM 2021; 3 (02) 100304
  • 22 Lawal OD, Gold J, Murthy A. et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open 2020; 3 (06) e207367
  • 23 Bosman J. Inside a Killer Drug Epidemic: A Look at America's Opioid Crisis. New York Times 2017. Accessed March 16, 2022 at: https://www.nytimes.com/2017/01/06/us/opioid-crisis-epidemic.html
  • 24 Adams J, Bledsoe GH, Armstrong JH. Are pain management questions in patient satisfaction surveys driving the opioid epidemic?. Am J Public Health 2016; 106 (06) 985-986
  • 25 Centers for Medicare & Medicaid. Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS): Centers for Medicare & Medicaid Services. 2015. Accessed March 16, 2021 at: https://hcahpsonline.org/en/survey-instruments/
  • 26 HCAHPS. Patients' Perspectives of Care Survey. Centers for Medicare and Medicaid Services, 2020. Accessed April 6, 2021 at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/HospitalHCAHPS
  • 27 Zgierska A, Rabago D, Miller MM. Impact of patient satisfaction ratings on physicians and clinical care. Patient Prefer Adherence 2014; 8: 437-446
  • 28 Duncan RW, Smith KL, Maguire M, Stader III DE. Alternatives to opioids for pain management in the emergency department decreases opioid usage and maintains patient satisfaction. Am J Emerg Med 2019; 37 (01) 38-44
  • 29 Holland E, Bateman BT, Cole N. et al. Evaluation of a quality improvement intervention that eliminated routine use of opioids after cesarean delivery. Obstet Gynecol 2019; 133 (01) 91-97
  • 30 Olsen N, Eagan A, Romutis K, Terplan M, Martin CE. Evaluation of a new departmental policy to decrease routine opioid prescribing after vaginal delivery. Am J Obstet Gynecol MFM 2020; 2 (03) 100156
  • 31 Prabhu M, McQuaid-Hanson E, Hopp S. et al. A shared decision-making intervention to guide opioid prescribing after cesarean delivery. Obstet Gynecol 2017; 130 (01) 42-46
  • 32 Schieber LZ, Guy Jr GP, Seth P. et al. Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017. JAMA Netw Open 2019; 2 (03) e190665
  • 33 Badreldin N, Grobman WA, Yee LM. Racial disparities in postpartum pain management. Obstet Gynecol 2019; 134 (06) 1147-1153